A0082 Translating visual benefit to oncologic benefit: Blue-light TURBT reduces recurrence in T1 and high-risk NMIBC

European Urology 2026

View at publisher

Authors: Mohd Rizal S. Binti, P. Gestopa, B.J.R. Barrass, F. Khan, A. Kooplikattil Pushkaran, V. Bodean

DOI: 10.1016/s0302-2838(26)00147-8

Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary Bladder and Prostate Research Urinary and Genital Oncology Studies